Organogenesis Holdings (ORGO) - Cash on Hand per Share

The stability of Organogenesis Holdings (ORGO) is based on the integration of biomaterials into surgical protocols, creating a reliable revenue stream. Leadership in tissue regeneration solidifies its gold standard status, while growing demand in diabetes care expands the customer base. The dynamics of the cash cushion per share confirm liquidity, while the 0.17 indicator reflects the status of the company's current reserves.
Comprehensive metric breakdowns and analytics for Organogenesis Holdings Inc. (ORGO)

The metric is calculated by dividing the total volume of highly liquid assets by the number of outstanding shares, determining the individual share of the investor's cash cushion. For Organogenesis (ORGO), a leader in tissue bioengineering, the cash per share chart serves as an indicator of the ability to fund expansion in the wound care segment without raising external capital, balancing solvency with resource efficiency.